Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says

J&J's consumer health unit Kenvue aims to raise $3.5 billion or more in the initial public offering, sources told the Wall Street Journal.

from Health and Science https://ift.tt/ZqoHEGk
https://ift.tt/4orzBdn
https://ift.tt/YZwISy8